Adastra Holdings Ltd. SEC filings XTXXF
Adastra Holdings Ltd. has 41 filings in SEC EDGAR's recent list, going back to Nov 8, 2021. Its latest annual report, Form 20-F, was filed on May 17, 2023 for the period ended Dec 31, 2022. The most recent current report (Form 6-K) was filed on Dec 6, 2023. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 15-12G | Deregistration | May 1, 2024 | — |
| NT 20-F | Form nt 20-f | Apr 26, 2023 | Dec 31, 2022 |
| D | Filing | Sep 6, 2022 | — |
| NT 20-F | Form nt 20-f | May 3, 2022 | Dec 31, 2021 |
| UPLOAD | Letter from the SEC | Mar 28, 2022 | — |
| CORRESP | Letter to the SEC | Mar 18, 2022 | — |
| 20FR12G/A | Form 20fr12g/a | Mar 18, 2022 | — |
| UPLOAD | Letter from the SEC | Mar 16, 2022 | — |
| CORRESP | Letter to the SEC | Mar 11, 2022 | — |
| 20FR12G/A | Form 20fr12g/a | Mar 11, 2022 | — |
| UPLOAD | Letter from the SEC | Mar 2, 2022 | — |
| CORRESP | Letter to the SEC | Feb 18, 2022 | — |
| 20FR12G/A | Form 20fr12g/a | Feb 18, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 7, 2022 | — |
| 20FR12G/A | Form 20-fr12g/a | Jan 21, 2022 | — |
| CORRESP | Letter to the SEC | Jan 20, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 6, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 7, 2021 | — |
| 20FR12G | Form 20fr12g | Nov 8, 2021 | — |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- XTXXF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Langley, British Columbia, Canada
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1891512
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.